And there is a growing recognition that the provider payment mechanism is a crucial area for future experimentation. Where to focus additional resources remains au area with a dearth of evidence at the macro level in many countries. There is little persuasive evidence on the macro benefits of primary care spending, and - with a few exceptions - the micro evidence is small scale and inconclusive, although there are indications of promising policy options for future experimentation.